Campath 30mg Injection

Zydus Cadila

Composition for Campath 30mg Injection

iconPrescription Required
1 Injection in 1 vial

Medicine Overview of Campath Injection


Uses of Campath Injection

Campath 30mg Injection is used in the treatment of blood cancer (Chronic lymphocytic leukemia) and multiple sclerosis (MS).

Side effects of Campath Injection


Rash, Headache, Insomnia (difficulty in sleeping), Nausea, Upper respiratory tract infection, Decreased white blood cell count, Fatigue, Fever, Itching, Flushing (sense of warmth in the face, ears, neck and trunk), Urticaria, Decreased white blood cell count (lymphocytes).


How to use Campath Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

How Campath Injection works

Campath 30mg injection is a monoclonal antibody. It flags the cancer cells for destruction by the body's immune system. It also modulates the immune system to limit its attacks on the nervous system.

In Depth Information on Campath Injection

Expert advice for Campath Injection

  • Alemtuzumab may sometimes cause life-threatening reactions like chest pain, breathlessness, slow or irregular heartbeat and therefore you will be closely monitored during and 2 hours after the infusion.
  • Seek immediate medication attention if you notice unusual bruising or bleeding, blood in urine, swelling of legs or feet, or if you cough up blood. 
  • Avoid activities that may increase your risk of bleeding or injury. Take necessary care to prevent bleeding while shaving or brushing your teeth. 
  • Serious infections may occur during alemtuzumab treatment. Inform doctor immediately if you develop fever, chills, cough, mouth sores, or trouble breathing.
  • Avoid contact with people who have infections.
  • Do not receive live vaccines if you have recently received alemtuzumab.
video imgplay img
Special precautions for Campath 30mg Injection
Interaction with alcohol is unknown. Please consult your doctor.
Campath 30mg Injection may be unsafe to use during pregnancy.

Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Campath 30mg Injection is probably usafe to use during lacta
tion. Limited human data suggests that the drug could represent a significant risk to the baby.
Campath 30mg Injection may make you feel dizzy, sleepy, tire
d, or decrease alertness. If this happens, do not drive.
There is limited information available on the use of Campath
30mg Injection in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Campath
30mg Injection in patients with liver disease. Please consult your doctor.

Missed Dosageuses

If you miss a dose of Alemtuzumab, please consult your doctor.
Related Articles

Patient Concerns

Frequently asked questions for Campath 30mg Injection

Frequently asked questions for Alemtuzumab

Campath is administered as an IV infusion over 2 hours (3mg/day) until infusion reactions are ≤grade 2, then 10mg/day on the alternate day and 30mg/day on the next alternate day. 30mg/day dose is continued every alternate day, for 12 weeks.
Yes, Campath is FDA approved for Multiple sclerosis

User Submitted Feedback For Campath 30mg Injection

Survey Participants: 3
“The following are the results of on-going survey on for Campath 30mg Injection. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”

Substitutes for Campath

No substitutes found for this medicine
Top Medical Oncologists
Dr. Amit Agarwal
MBBS, MD, DM, Fellowship
Dr. Jawahar Ticku
MBBS, MD, Fellowship
cross img